Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

Abilify

The Top Pharma List's top 50 pharmaceutical products by global sales ranking is compiled from GlobalData's pharmaceutical revenue figures. Abilify was produced by Otsuka and Bristol-Myers Squibb.

Proteus: Digital medicines set to transform healthcare

Proteus: Digital medicines set to transform healthcare The companies submitted for approval a sensor-enabled version of Otsuka's Abilify (aripriprazole), a treatment for patients with schizophrenia, bi-polar and other mental health disorders.

Allergan and Gedeon finally get antipsychotic green light

Allergan and Gedeon finally get antipsychotic green light Once-monthly examples include Otsuka/Lundbeck's Abilify Maintena (aripiprazole) and Johnson and Johnson's Invega Sustenna (paliperidone palmitate), while J&J is also developing a three-monthly paliperidone depot that

J&J files three-monthly schizophrenia drug in Europe

J&J files three-monthly schizophrenia drug in Europe over other once-monthly rivals such as Lilly's Zypadhera (olanzapine) and Lundbeck's Abilify Maintena (aripiprazole), launched in Europe last year.

Lundbeck to cut 1,000 jobs in major restructure

Lundbeck to cut 1,000 jobs in major restructure Lundbeck's focus will now turn more to its newer drugs such as Brintellix (vortioxetine), Northera (droxidopa), Onfi (clobazam) and Abilify Maintena (aripriprazole) which saw a 190% growth in sales. .

Lundbeck and Otsuka's Rexulti set for August launch in US

Lundbeck and Otsuka's Rexulti set for August launch in US Rexulti (brexpiprazole) is a dopamine D2 and serotonin 5-HT1A partial agonist positioned as a successor to the Otsuka's big-selling atypical antipsychotic Abilify (aripiprazole), which is sold by ... Abilify's primary use is in schizophrenia and bipolar

[ Previous 5 results ] 1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Accession

Accession was a born from a passion and a vision. A passion to harness the power of market access to...

Latest intelligence

From lay summaries to patient engagement programmes: how patient-centricity is finally becoming a reality
How pharma is progressing their commitment in patient engagement...
Cuttsy+Cuttsy awarded CPD Platinum by the IPA
Four years after being awarded Gold for their continuous professional development (CPD) Cuttsy+Cuttsy (C+C) have reached another milestone and been awarded Platinum accreditation....
Breaking Bad
Six behaviours separate the good brand teams from the bad...

Infographics